The world of cancer treatment is rapidly advancing. Scientists are discovering new ways to target cancers, making drugs more effective and more precise. But with these new advancements, comes a long process of approvals involving many steps to allow Canadians to access them. Not only do new drugs need to be approved for safety and efficacy by regulatory bodies like Health Canada and the Canadian Drug Agency, but then they also need to go through price negotiations between the drug manufacturers and the provinces . These negotiations set the cost that every province will pay to the drug company once the drug is added to public drug plans.

Having a solid strategy for gathering trusted and dependable information is critical for making informed treatment decisions when it comes to your health.  It is also important to be able to communicate assertively with healthcare practitioners as an equal partner in shared decision-making.

2023 was a year of many changes, and CBCN’s work reflects that. In this post, we look back on some of the many activities and projects that we participated in, developed, or updated. With each development, CBCN is committed to ensuring that breast cancer patients and survivors are the driving force of the organization and that their views and concerns inform our priorities.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on October 3, 2023. In this session, Surgical Oncologist Dr. Mark Basik answers your questions about clinical trials. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on September 19, 2023. In this session, Dr. Tina Hsu, MD, FRCPC answers all your questions about navigating a breast cancer diagnosis at an older age. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on September 12, 2023. In this session, General Practitioner in Oncology Dr. Anna Wilkinson, FP, GPO answers your questions about post-treatment and survivorship care. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on February 20th, 2023. In this session, Certified Lymphedema Therapist Marize Ibrahim answers your questions about breast cancer-related lymphedema.

A breast cancer diagnosis comes with so many questions and there never seems to be enough time at appointments to have some of these questions answered. To help address this, we developed a "Q&E: Questions and Experts" series. In this series, a variety of experts spend the entire virtual session answering pre-submitted and live questions from participants. Watching the videos on-demand might be a little difficult to get through. So, we’ve created this guide to help you get right to the questions and answers that matter the most to you

A breast cancer diagnosis comes with so many questions and there never seems to be enough time at appointments to have some of these questions answered. To help address this, we developed a "Q&E: Questions and Experts" series. In this series, a variety of experts spend the entire virtual session answering pre-submitted and live questions from participants. Watching the videos on-demand might be a little difficult to get through. So, we’ve created this guide to help you get right to the questions and answers that matter the most to you.

The past year allowed us a return to a more normal routine in a lot of ways, and our blogs from 2022 reflect that. Posts about being able to gather for the holidays, get mastectomy tattoos, and having in-person healthcare visits were some of the topics of our top 10 blog posts from last year.